TSX:AVCN - Toronto Stock Exchange - CA05368K1003 - Common Stock - Currency: CAD
TSX:AVCN (4/30/2025, 7:00:00 PM)
0.245
0 (0%)
The current stock price of AVCN.CA is 0.245 CAD. In the past month the price decreased by -9.26%. In the past year, price decreased by -30%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
WEED-DB.CA | CANOPY GROWTH CORP | N/A | 9.54B | ||
BHC.CA | BAUSCH HEALTH COS INC | 1.41 | 2.71B | ||
CRON.CA | CRONOS GROUP INC | 18.5 | 998.21M | ||
TLRY.CA | TILRAY BRANDS INC | N/A | 684.42M | ||
DHT-UN.CA | DRI HEALTHCARE TRUST | 5.3 | 647.57M | ||
GUD.CA | KNIGHT THERAPEUTICS INC | 121.6 | 604.66M | ||
WEED.CA | CANOPY GROWTH CORP | N/A | 399.25M | ||
ACB.CA | AURORA CANNABIS INC | 27.83 | 351.10M | ||
CPH.CA | CIPHER PHARMACEUTICALS INC | 21.13 | 346.38M | ||
HITI.CA | HIGH TIDE INC | N/A | 268.72M | ||
TSND.CA | TERRASCEND CORP | N/A | 220.81M | ||
OGI.CA | ORGANIGRAM GLOBAL INC | N/A | 216.72M |
Avicanna, Inc. is a medical cannabis company, which intends to engage in the business of discovery and development processes, intellectual property portfolio, strategic relationships, and cultivation infrastructure. The company is headquartered in Toronto, Ontario. The company went IPO on 2019-07-18. The firm's scientific platform commercializes over thirty products across various market segments: Medical Cannabis formulary (RHO Phyto), Medical cannabis care platform (MyMedi.ca), Pharmaceutical pipeline, and Active pharmaceutical ingredients (Aureus Santa Marta). RHO Phyto formulary offers a diverse range of proprietary products, including oral, sublingual, topical, and transdermal deliveries with varying ratios of cannabinoids. MyMedi.ca is a medical cannabis care platform and features a diverse portfolio of products and bilingual pharmacist-led patient support programs. Aureus Santa Mart is a commercial-stage business providing a various forms CBD, THC and CBG to the Company's international partners for use in the development and production of food, cosmetics, medical, and pharmaceutical products.
AVICANNA INC
480 University Avenue, Suite 1502
TORONTO ONTARIO M5G 1V2 CA
CEO: Aras Azadian
Employees: 87
Company Website: https://avicanna.com/
Investor Relations: http://ir.avicanna.com/ir/financial-documents/
Phone: 16472435283
The current stock price of AVCN.CA is 0.245 CAD.
The exchange symbol of AVICANNA INC is AVCN and it is listed on the Toronto Stock Exchange exchange.
AVCN.CA stock is listed on the Toronto Stock Exchange exchange.
AVICANNA INC (AVCN.CA) has a market capitalization of 27.00M CAD. This makes AVCN.CA a Nano Cap stock.
AVICANNA INC (AVCN.CA) currently has 87 employees.
AVICANNA INC (AVCN.CA) has a support level at 0.23 and a resistance level at 0.25. Check the full technical report for a detailed analysis of AVCN.CA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
AVCN.CA does not pay a dividend.
AVICANNA INC (AVCN.CA) will report earnings on 2025-05-19.
AVICANNA INC (AVCN.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.07).
ChartMill assigns a fundamental rating of 2 / 10 to AVCN.CA. The financial health of AVCN.CA is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months AVCN.CA reported a non-GAAP Earnings per Share(EPS) of -0.07. The EPS increased by 52% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -33.22% | ||
ROE | -396.25% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 40% to AVCN.CA. The Buy consensus is the average rating of analysts ratings from 9 analysts.